Literature DB >> 12134623

Pancreatitis as a risk for pancreatic cancer.

David C Whitcomb1, Katherine Pogue-Geile.   

Abstract

Chronic pancreatitis clearly predisposes to pancreatic cancer, with early onset-long duration chronic pancreatitis from cystic fibrosis, TP, and HP conferring the highest risk. Chronic pancreatitis is not a critical step, however, but rather one of several conditions that accelerate the accumulation of critical genetic mutations and chromosomal losses necessary for carcinogenesis. Indeed, other germline mutations, environmental factors such as tobacco smoking and alcohol consumption, or dietary factors may also accelerate the pathway to carcinogenesis, and may be synergistic with the conditions created by chronic pancreatitis. Because patients with chronic pancreatitis are at high risk of pancreatic cancer, the physician is faced with decisions on how to manage this risk. Discontinuing smoking and alcohol consumption, and perhaps dietary modification are obvious recommendations for risk reduction. If, however, the patient is older and already in a very high-risk category (e.g., long-standing HP), then screening for cancers must be considered. Inclusion in multicenter trials is recommended, and information on ongoing studies can be obtained through the office of Dr. Whitcomb, or as posted on www.pancreas.org.

Entities:  

Mesh:

Year:  2002        PMID: 12134623     DOI: 10.1016/s0889-8553(02)00004-3

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  20 in total

Review 1.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development.

Authors:  Weidan Peng; Narumi Furuuchi; Ludmila Aslanukova; Yu-Hung Huang; Samantha Z Brown; Wei Jiang; Sankar Addya; Vikalp Vishwakarma; Erika Peters; Jonathan R Brody; Dan A Dixon; Janet A Sawicki
Journal:  Mol Cell Biol       Date:  2018-01-16       Impact factor: 4.272

3.  CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice.

Authors:  Yaqing Zhang; Wei Yan; Esha Mathew; Filip Bednar; Shanshan Wan; Meredith A Collins; Rebecca A Evans; Theodore H Welling; Robert H Vonderheide; Marina Pasca di Magliano
Journal:  Cancer Immunol Res       Date:  2014-02-11       Impact factor: 11.151

Review 4.  Imaging in pancreatic disease.

Authors:  Julien Dimastromatteo; Teresa Brentnall; Kimberly A Kelly
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-09       Impact factor: 46.802

5.  Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.

Authors:  Rachelle E Stopczynski; Daniel P Normolle; Douglas J Hartman; Haoqiang Ying; Jennifer J DeBerry; Klaus Bielefeldt; Andrew D Rhim; Ronald A DePinho; Kathryn M Albers; Brian M Davis
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

6.  A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.

Authors:  Bridget P Keenan; Yvonne Saenger; Michel I Kafrouni; Ashley Leubner; Peter Lauer; Anirban Maitra; Agnieszka A Rucki; Andrew J Gunderson; Lisa M Coussens; Dirk G Brockstedt; Thomas W Dubensky; Raffit Hassan; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Gastroenterology       Date:  2014-03-06       Impact factor: 22.682

7.  Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.

Authors:  Janusz Franco-Barraza; Ralph Francescone; Tiffany Luong; Neelima Shah; Raj Madhani; Gil Cukierman; Essel Dulaimi; Karthik Devarajan; Brian L Egleston; Emmanuelle Nicolas; R Katherine Alpaugh; Ruchi Malik; Robert G Uzzo; John P Hoffman; Erica A Golemis; Edna Cukierman
Journal:  Elife       Date:  2017-01-31       Impact factor: 8.140

Review 8.  Alcohol consumption on pancreatic diseases.

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Jesus Maria Bañales; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 9.  Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-07-01       Impact factor: 7.638

Review 10.  Discovering the route from inflammation to pancreatic cancer.

Authors:  N Momi; S Kaur; S R Krishn; S K Batra
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.